Prognostic value of programmed death-ligand 1 (PD-L1) expression in patients with stage III colorectal cancer.

Shigehiro Koganemaru,Naoko Inoshita,Yuji Miura,Yudai Fukui,Yukinori Ozaki,Kenji Tomizawa,Yutaka Hanaoka,Shigeo Toda,Koichi Suyama,Yuko Tanabe,Jin Moriyama,Takeshi Fujii,Shuichiro Matoba,Hiroya Kuroyanagi,Toshimi Takano

Prognostic value of programmed death-ligand 1 (PD-L1) expression in patients with stage III colorectal cancer.

2016

Shigehiro Koganemaru
Naoko Inoshita
Yuji Miura
Yudai Fukui
Yukinori Ozaki
Kenji Tomizawa
Yutaka Hanaoka
Shigeo Toda
Koichi Suyama
Yuko Tanabe
Jin Moriyama
Takeshi Fujii
Shuichiro Matoba
Hiroya Kuroyanagi
Toshimi Takano

3568Background: The programmed death-1 (PD-1)/PD-L1 pathway is a negative feedback mechanism that suppresses the activity of T cells. PD-L1 was expressed on tumor cells (TCs) or tumor-infiltrating ...

Keywords:

PD-L1
Stage III colorectal cancer
Oncology
Ligand
Internal medicine
Medicine
in patient
programmed death
pd l1 expression
tumor cells

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations